DIEBOLD NIXDORF INC (DBD) Stock Fundamental Analysis
USA - NYSE:DBD - US2536512021 - Common Stock
57.66 USD
+0.99 (+1.75%)
Overall DBD gets a fundamental rating of 4 out of 10. We evaluated DBD against 34 industry peers in the Technology Hardware, Storage & Peripherals industry. Both the profitability and the financial health of DBD get a neutral evaluation. Nothing too spectacular is happening here. DBD has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year DBD was profitable.
DBD had a positive operating cash flow in the past year.
DBD had negative earnings in 4 of the past 5 years.
In multiple years DBD reported negative operating cash flow during the last 5 years.
1.2 Ratios
DBD has a Return On Assets of -0.34%. This is comparable to the rest of the industry: DBD outperforms 58.82% of its industry peers.
Looking at the Return On Equity, with a value of -1.18%, DBD is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
With a decent Return On Invested Capital value of 8.61%, DBD is doing good in the industry, outperforming 67.65% of the companies in the same industry.
DBD had an Average Return On Invested Capital over the past 3 years of 5.12%. This is significantly below the industry average of 14.92%.
The last Return On Invested Capital (8.61%) for DBD is above the 3 year average (5.12%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.34% | ||
| ROE | -1.18% | ||
| ROIC | 8.61% |
ROA(3y)4.54%
ROA(5y)0.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.12%
ROIC(5y)5.58%
1.3 Margins
Looking at the Operating Margin, with a value of 7.32%, DBD is in the better half of the industry, outperforming 73.53% of the companies in the same industry.
In the last couple of years the Operating Margin of DBD has grown nicely.
DBD has a Gross Margin of 25.44%. This is comparable to the rest of the industry: DBD outperforms 41.18% of its industry peers.
DBD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.32% | ||
| PM (TTM) | N/A | ||
| GM | 25.44% |
OM growth 3Y20.78%
OM growth 5Y40.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.32%
GM growth 5Y0.68%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DBD is destroying value.
The number of shares outstanding for DBD remains at a similar level compared to 1 year ago.
Compared to 5 years ago, DBD has less shares outstanding
DBD has a better debt/assets ratio than last year.
2.2 Solvency
DBD has an Altman-Z score of 1.84. This is not the best score and indicates that DBD is in the grey zone with still only limited risk for bankruptcy at the moment.
DBD's Altman-Z score of 1.84 is in line compared to the rest of the industry. DBD outperforms 47.06% of its industry peers.
DBD has a debt to FCF ratio of 4.62. This is a neutral value as DBD would need 4.62 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.62, DBD is doing good in the industry, outperforming 67.65% of the companies in the same industry.
A Debt/Equity ratio of 0.85 indicates that DBD is somewhat dependend on debt financing.
DBD has a Debt to Equity ratio of 0.85. This is in the lower half of the industry: DBD underperforms 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 4.62 | ||
| Altman-Z | 1.84 |
ROIC/WACC0.92
WACC9.34%
2.3 Liquidity
A Current Ratio of 1.36 indicates that DBD should not have too much problems paying its short term obligations.
The Current ratio of DBD (1.36) is comparable to the rest of the industry.
A Quick Ratio of 0.91 indicates that DBD may have some problems paying its short term obligations.
With a Quick ratio value of 0.91, DBD perfoms like the industry average, outperforming 55.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
DBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.20%, which is quite good.
The Earnings Per Share has been growing by 69.69% on average over the past years. This is a very strong growth
The Revenue has decreased by -3.75% in the past year.
Measured over the past years, DBD shows a decrease in Revenue. The Revenue has been decreasing by -3.18% on average per year.
EPS 1Y (TTM)13.2%
EPS 3Y69.69%
EPS 5YN/A
EPS Q2Q%-18.26%
Revenue 1Y (TTM)-3.75%
Revenue growth 3Y-1.33%
Revenue growth 5Y-3.18%
Sales Q2Q%-2.61%
3.2 Future
The Earnings Per Share is expected to grow by 11.87% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.83% on average over the next years.
EPS Next Y-3.58%
EPS Next 2Y13.88%
EPS Next 3Y11.87%
EPS Next 5YN/A
Revenue Next Year2.09%
Revenue Next 2Y2.41%
Revenue Next 3Y2.83%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
DBD is valuated rather expensively with a Price/Earnings ratio of 20.37.
DBD's Price/Earnings ratio is a bit cheaper when compared to the industry. DBD is cheaper than 76.47% of the companies in the same industry.
When comparing the Price/Earnings ratio of DBD to the average of the S&P500 Index (27.57), we can say DBD is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 11.52, the valuation of DBD can be described as reasonable.
Based on the Price/Forward Earnings ratio, DBD is valued a bit cheaper than 76.47% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.09, DBD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.37 | ||
| Fwd PE | 11.52 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DBD indicates a rather cheap valuation: DBD is cheaper than 97.06% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, DBD is valued cheaply inside the industry as 82.35% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.48 | ||
| EV/EBITDA | 6.7 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.88%
EPS Next 3Y11.87%
5. Dividend
5.1 Amount
No dividends for DBD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:DBD (10/23/2025, 12:39:49 PM)
57.66
+0.99 (+1.75%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners105.22%
Inst Owner Change-0.07%
Ins Owners1.78%
Ins Owner Change0.24%
Market Cap2.11B
Revenue(TTM)3.67B
Net Income(TTM)-12900000
Analysts82.86
Price Target77.18 (33.85%)
Short Float %2.35%
Short Ratio4.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.65%
Min EPS beat(2)1.76%
Max EPS beat(2)59.55%
EPS beat(4)2
Avg EPS beat(4)0.05%
Min EPS beat(4)-52.17%
Max EPS beat(4)59.55%
EPS beat(8)5
Avg EPS beat(8)9.34%
EPS beat(12)7
Avg EPS beat(12)-88.46%
EPS beat(16)8
Avg EPS beat(16)-91.11%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)3.02%
Revenue beat(4)1
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-1.34%
Max Revenue beat(4)3.02%
Revenue beat(8)4
Avg Revenue beat(8)0.04%
Revenue beat(12)4
Avg Revenue beat(12)-0.96%
Revenue beat(16)4
Avg Revenue beat(16)-2.35%
PT rev (1m)0%
PT rev (3m)4.61%
EPS NQ rev (1m)-3.63%
EPS NQ rev (3m)-13.86%
EPS NY rev (1m)6.5%
EPS NY rev (3m)4.99%
Revenue NQ rev (1m)-1.23%
Revenue NQ rev (3m)-4.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.37 | ||
| Fwd PE | 11.52 | ||
| P/S | 0.58 | ||
| P/FCF | 10.48 | ||
| P/OCF | 9.32 | ||
| P/B | 1.92 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.7 |
EPS(TTM)2.83
EY4.91%
EPS(NY)5.01
Fwd EY8.68%
FCF(TTM)5.5
FCFY9.55%
OCF(TTM)6.18
OCFY10.72%
SpS100.25
BVpS29.95
TBVpS-9.82
PEG (NY)N/A
PEG (5Y)N/A
Graham Number43.67
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.34% | ||
| ROE | -1.18% | ||
| ROCE | 10.9% | ||
| ROIC | 8.61% | ||
| ROICexc | 9.77% | ||
| ROICexgc | 29.69% | ||
| OM | 7.32% | ||
| PM (TTM) | N/A | ||
| GM | 25.44% | ||
| FCFM | 5.49% |
ROA(3y)4.54%
ROA(5y)0.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.12%
ROIC(5y)5.58%
ROICexc(3y)6.13%
ROICexc(5y)6.88%
ROICexgc(3y)21.8%
ROICexgc(5y)29.05%
ROCE(3y)6.48%
ROCE(5y)7.06%
ROICexgc growth 3Y-11.73%
ROICexgc growth 5Y37.89%
ROICexc growth 3Y4.77%
ROICexc growth 5Y35.34%
OM growth 3Y20.78%
OM growth 5Y40.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.32%
GM growth 5Y0.68%
F-Score4
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 4.62 | ||
| Debt/EBITDA | 2.31 | ||
| Cap/Depr | 18.6% | ||
| Cap/Sales | 0.68% | ||
| Interest Coverage | 2.84 | ||
| Cash Conversion | 56.26% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 1.84 |
F-Score4
WACC9.34%
ROIC/WACC0.92
Cap/Depr(3y)16.93%
Cap/Depr(5y)15.92%
Cap/Sales(3y)0.61%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.2%
EPS 3Y69.69%
EPS 5YN/A
EPS Q2Q%-18.26%
EPS Next Y-3.58%
EPS Next 2Y13.88%
EPS Next 3Y11.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.75%
Revenue growth 3Y-1.33%
Revenue growth 5Y-3.18%
Sales Q2Q%-2.61%
Revenue Next Year2.09%
Revenue Next 2Y2.41%
Revenue Next 3Y2.83%
Revenue Next 5YN/A
EBIT growth 1Y3.35%
EBIT growth 3Y19.17%
EBIT growth 5Y36.19%
EBIT Next Year24.77%
EBIT Next 3Y13.69%
EBIT Next 5YN/A
FCF growth 1Y145.49%
FCF growth 3Y8.67%
FCF growth 5Y113.09%
OCF growth 1Y154.49%
OCF growth 3Y6.68%
OCF growth 5Y26.59%